HUTCHMED (China) (HCM) Beginning Cash Balance (2018 - 2021)
HUTCHMED (China)'s (HCM) quarterly Beginning Cash Balance came in at $235.6 million in Q1 2021, up 94.48% year-on-year from $121.2 million in Q1 2020, and up 94.48% on a QoQ basis from $121.2 million in Q1 2020.
HUTCHMED (China) (HCM) Beginning Cash Balance (2018 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has 4 years of Beginning Cash Balance data on file, last reported at $235.6 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 235.63 Mn |
| Mar 31, 2021 | 235.63 Mn |
| Mar 31, 2020 | 121.16 Mn |
| Mar 31, 2020 | 121.16 Mn |
| Mar 31, 2019 | 86.04 Mn |
| Mar 31, 2019 | 86.04 Mn |
| Mar 31, 2018 | 85.27 Mn |
| Mar 31, 2018 | 85.27 Mn |